AEGERION PHARMACEUTICALS INC's ticker is AEGR and the CUSIP is 00767E102. A total of 111 filers reported holding AEGERION PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $340,000 | -31.6% | 25,000 | +31.6% | 0.02% | -31.8% |
| Q1 2015 | $497,000 | +18.6% | 19,000 | -5.0% | 0.02% | +57.1% |
| Q4 2014 | $419,000 | -58.1% | 20,000 | -33.3% | 0.01% | -41.7% |
| Q3 2014 | $1,001,000 | +3.9% | 30,000 | 0.0% | 0.02% | +14.3% |
| Q2 2014 | $963,000 | -29.8% | 30,000 | +0.9% | 0.02% | -25.0% |
| Q1 2014 | $1,372,000 | +51.4% | 29,720 | +132.7% | 0.03% | +40.0% |
| Q4 2013 | $906,000 | – | 12,770 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADVENT INTERNATIONAL, L.P. | 447,001 | $14,344,000 | 100.00% |
| Broadfin Capital, LLC | 1,620,088 | $51,988,000 | 2.56% |
| SCOPIA CAPITAL MANAGEMENT LP | 2,899,585 | $93,048,000 | 2.40% |
| Tamarack Capital Management, LLC | 400,000 | $11,656,000 | 2.38% |
| March Altus Capital Management LP | 199,037 | $6,387,000 | 2.34% |
| PRICE MICHAEL F | 240,000 | $7,702,000 | 0.94% |
| DELTEC ASSET MANAGEMENT LLC | 106,151 | $3,406,000 | 0.72% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 3,207,598 | $102,932,000 | 0.61% |
| CLOUGH CAPITAL PARTNERS L P | 508,800 | $16,327,000 | 0.52% |
| Catalyst Capital Advisors LLC | 86,500 | $2,776,000 | 0.45% |